BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid

Reuters

03-29

BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid

March 28 (Reuters) - bluebird bio Inc BLUE.O:

BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID
RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE
AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES
BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS
NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL

Source text: ID:nBwb6Pg2da

Further company coverage: BLUE.O

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2523663851"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2523663851\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2523663851?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-29 04:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2523663851","market":"nz","top_or_hot":-1,"title":"BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid</title></head><body><p><span>March 28 (Reuters)</span><span> - </span>bluebird bio Inc <span>BLUE.O</span>:</p><ul><li><p>BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID</p></li><li><p>RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE</p></li><li><p>AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES</p></li><li><p>BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS</p></li><li><p>NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL</p></li></ul><p>Source text: <span>ID:nBwb6Pg2da</span></p><p>Further company coverage: <span>BLUE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-29 04:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From Ayrmid</title></head><body><p><span>March 28 (Reuters)</span><span> - </span>bluebird bio Inc <span>BLUE.O</span>:</p><ul><li><p>BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID</p></li><li><p>RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE</p></li><li><p>AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES</p></li><li><p>BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS</p></li><li><p>NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL</p></li></ul><p>Source text: <span>ID:nBwb6Pg2da</span></p><p>Further company coverage: <span>BLUE.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA5QK0RN:1","article_id":"2523663851","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2523663851","pubTimestamp":1743193457,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From AyrmidMarch 28 (Reuters) - bluebird bio Inc BLUE.O:BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"简介-Bluebird Bio确认收到Ayrmid主动提出的不具约束力的提案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLUE":0.9},"content_text":"BRIEF-Bluebird Bio Confirms Receipt Of An Unsolicited Non-Binding Proposal From AyrmidMarch 28 (Reuters) - bluebird bio Inc BLUE.O:BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMIDRECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHAREAYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVESBOARD REVIEWING AYRMID PROPOSAL WITH ADVISORSNOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEALSource text: ID:nBwb6Pg2daFurther company coverage: BLUE.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}